SKP2 and non-small cell lung carcinoma: He et al. demonstrated that BA inhibits NSCLC metastasis by direct interaction with Skp2, thereby blocking the assembly of the Skp2-SCF E3 ligase complex, which causes impairment of the ubiquitin-dependent degradation of its downstream target E-cadherin [179].